Patients with celiac disease have double the incidence rate of chronic liver disease compared with those without this ...
Crohn s disease is a chronic inflammatory disease of the gastrointestinal tract, mostly affecting the ileum. The inflammation can extend through the intestinal wall and tends to be asymmetric and ...
“When patients have a flare-up of Crohn’s, they can have anemia,” says William Sandborn, MD, the chief of gastroenterology and the director of the inflammatory bowel disease center at the ...
For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...
Celiac disease results from eating foods containing gluten. It’s also limited to the small intestine. Crohn’s disease can affect any part of the digestive tract and appears to be related to ...
Celiac disease is associated with an increased risk for developing alopecia areata, according to a letter to the editor published online in the Journal of the American Academy of Dermatology. Rashwan ...
Gaylyn Henderson, MPH, was diagnosed with Crohn's disease at age 14 and lives with a permanent ileostomy. She founded the organization Gutless and Glamorous with the mission of empowering those ...
Whenever gluten is consumed in people with celiac disease, the immune system will view the protein as harmful and launch an inflammatory attack, damaging villi. Crohn's disease is a type of ...
It causes inflammation and ulcers to develop along the lining of the colon and rectum. Celiac disease is also a lifelong condition. It occurs when gluten in the diet causes digestive problems.
Season of birth, genetic factors, and early-life infections impact celiac disease autoimmunity risk, with significant effects in children with specific gene variants. The TEDDY study found ...
Celiac disease and Crohn’s disease affect the small intestine. Ulcerative colitis and diverticulitis affect the large intestine. Irritable bowel syndrome (IBS) impacts both. Malnutrition Malnutrition ...
Europe’s first biomarker trial seeks to prevent Crohn’s Disease onset In a landmark effort, the INTERCEPT project has launched Europe’s first biomarker trial aimed at preventing Crohn’s Disease before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results